Encision Inc (ECIA) stock
ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $163.15KP/E –Yield –
Encision revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Encision's revenue for the twelve months ending Sep 30, 2025 was $6.30M, down 3.0% year over year. For fiscal 2025 it was $6.56M, down 0.5% from the year before. Over ten years it grew -3.8% a year on average. The highest annual figure on record is $12.99M in fiscal 2012.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $6.56M | -0.5% |
| FY2024 | Mar 31, 2024 | $6.59M | -10.4% |
| FY2023 | Mar 31, 2023 | $7.35M | -4.2% |
| FY2022 | Mar 31, 2022 | $7.67M | +1.7% |
| FY2021 | Mar 31, 2021 | $7.54M | -1.7% |
| FY2020 | Mar 31, 2020 | $7.67M | -12.9% |
| FY2019 | Mar 31, 2019 | $8.80M | +0.6% |
| FY2018 | Mar 31, 2018 | $8.75M | -1.3% |
| FY2017 | Mar 31, 2017 | $8.87M | -5.0% |
| FY2016 | Mar 31, 2016 | $9.34M | -3.5% |
| FY2015 | Mar 31, 2015 | $9.67M | -8.3% |
| FY2014 | Mar 31, 2014 | $10.55M | -10.4% |
| FY2013 | Mar 31, 2013 | $11.77M | -9.4% |
| FY2012 | Mar 31, 2012 | $12.99M | +11.8% |
| FY2011 | Mar 31, 2011 | $11.62M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $1.53M | -13.0% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $1.60M | -1.7% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $1.58M | +3.9% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $1.59M | +0.3% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $1.76M | -3.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $1.63M | -1.4% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $1.52M | -15.6% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $1.58M | -6.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $1.83M | +7.2% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $1.65M | -23.3% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $1.81M | +12.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $1.68M | -13.4% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $1.70M | -19.3% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $2.15M | +7.3% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $1.60M | -25.3% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $1.94M | -10.1% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $2.11M | +12.4% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $2.01M | +49.0% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $2.15M | +20.7% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $2.16M | +6.1% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $1.88M | -2.3% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $1.35M | -30.1% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $1.78M | -14.7% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $2.04M | -3.7% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $1.92M | -12.4% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $1.93M | -19.8% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $2.08M | +2.3% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $2.12M | -3.3% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $2.20M | +1.6% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $2.40M | +1.7% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $2.04M | -7.9% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $2.19M | -1.8% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $2.16M | +0.6% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $2.36M | +3.8% |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $2.21M | -3.4% |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $2.23M | -2.7% |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $2.15M | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | $2.28M | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $2.29M | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $2.29M | – |
See a number that looks wrong?